• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • TR-Dizin İndeksli Yayınlar Koleksiyonu
  • View Item
  •   RTEÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • TR-Dizin İndeksli Yayınlar Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Can Buspirone be a remedy for an SSRI / SNRI-induced Bruxism?

Thumbnail

View/Open

Full Text / Tam Metin (286.1Kb)

Access

info:eu-repo/semantics/openAccess

Date

2021

Author

Tandemir, Sultan Efsun
Geniş, Bahadır
Aksu, Muhammed Hakan
Hocaoğlu, Çiçek

Metadata

Show full item record

Citation

Tandemir, S.E., Genis, B., Aksu, M.H. & Hocaoglu, C. (2021). Buspiron, SSRI / SNRI kaynaklı bruksizm içinbir çözüm olabilir mi?. Klinik Psikiyatri Dergisi, 24(2), 246 - 256. 10.5505/kpd.2020.63496

Abstract

Bruxism is a parafunctional activity characterized by daytime (diurnal) or nighttime (nocturnal) tooth grinding and squeezing and causing various pathologies in oropharyngeal tissues. Buspirone is used in the treatment of generalized anxiety disorder, to reduce the side effects of selective serotonin reuptake inhibitors, and to strengthen the treatment in depression and anxiety disorders. In addition to these uses, buspirone is also used in the treatment of bruxism in adults. In this study, it is aimed to summarize bruxism cases treated with buspirone in literature and to discuss treatment options. A systematic research was conducted on Pubmed, Google Academic and Web of Science databases to evaluate all peer-reviewed articles using buspirone in the treatment of bruxism. The whole study in which buspirone was used in the treatment of bruxism was included in the study. When evaluated on the basis of case reports, buspirone is seen as one of the psychotropes that can be used safely in the treatment of bruxism. In the treatment, it may be recommended to adjust the average daily dose to 10-20 mg and wait a minimum of 2 weeks, although the effectiveness may occur in a much shorter time. This study is important in terms of recommending buspirone, which has been shown to be effective in the treatment of bruxism in many cases, despite its various limitations and as a step for further studies on this subject.

Source

Klinik Psikiyatri Dergisi

Volume

24

Issue

2

URI

https://klinikpsikiyatri.org/eng/jvi.aspx?pdir=kpd&plng=eng&un=KPD-63496&look4=
https://hdl.handle.net/11436/6383

Collections

  • Scopus İndeksli Yayınlar Koleksiyonu [6000]
  • TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu [1571]
  • TR-Dizin İndeksli Yayınlar Koleksiyonu [2844]
  • WoS İndeksli Yayınlar Koleksiyonu [5260]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Instruction | Guide | Contact |

DSpace@RTEÜ

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution AuthorThis CollectionBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution Author

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide|| Instruction || Library || Recep Tayyip Erdoğan University || OAI-PMH ||

Recep Tayyip Erdoğan University, Rize, Turkey
If you find any errors in content, please contact:

Creative Commons License
Recep Tayyip Erdoğan University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@RTEÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.